William Wilke, M.D.

William S. Wilke, MD, is a Staff member in the Department of Rheumatic and Immunologic Disease at Cleveland Clinic. He was appointed in 1977 after completing a special fellowship in the Department of Rheumatic and Immunologic Disease at Cleveland Clinic.

 

His clinical interests include rheumatoid arthritis and fibromyalgia.

 

Dr. Wilke received his medical degree from the Medical College of Wisconsin (Marquette) and he completed an internship and an internal medicine residency at Akron City Hospital.

 

Dr. Wilke has written numerous journal articles, abstracts, letters and book chapters. Until recently, he served as the associate editor of the Cleveland Clinic Journal of Medicine. During his career, he has been a member of the American College of Rheumatology, the Cleveland Rheumatism Society, the Ohio Society of Rheumatology, the Ohio Society of Internal Medicine, the Cleveland Academy of Medicine, the Northeastern Ohio Chapter of the Arthritis Foundation, the American Federation for Clinical Research, and the American Association for the Advancement of Science.

Drug treatment of rheumatoid arthritis, giant cell arteritis, polymyalgia rheumatica, fibromyalgia, chronic fatigue syndrome, sjogren's syndrome.

• Designing a "Shared Visit" Program with Cleveland Clinic's Orthopedic Surgery Physical Therapy for patients with fibromyalgia, which will provide both education and aerobic training.

• "Meet the Professor" for the treatment of rheumatoid arthritis for the American College of Rheumatology, 1990-1992.

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/7/2008, Dr. Wilke has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting.  Dr. Wilke receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:

• Pfizer Inc.
• UCB Pharma, Inc.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)